Department of Internal Medicine, Section of Gerontology and Geriatrics, Leiden University Medical Center, Leiden, the Netherlands.
Department of Internal Medicine, Section of Gerontology and Geriatrics, Leiden University Medical Center, Leiden, the Netherlands; Department of Clinical Epidemiology, Leiden University Medical Center, Leiden, the Netherlands.
Atherosclerosis. 2022 Aug;354:1-7. doi: 10.1016/j.atherosclerosis.2022.06.1012. Epub 2022 Jun 19.
Mitochondrial dysfunction is associated with increased reactive oxygen species (ROS) that are thought to drive disease risk, including stroke. We investigated the association between mtDNA abundance, as a proxy measure of mitochondrial function, and incident stroke, using multivariable-adjusted survival and Mendelian Randomization (MR) analyses.
Cox-proportional hazard model analyses were conducted to assess the association between mtDNA abundance, and incident ischemic and hemorrhagic stroke over a maximum of 14-year follow-up in European-ancestry participants from UK Biobank. MR was conducted using independent (R < 0.001) lead variants for mtDNA abundance (p < 5 × 10) as instrumental variables. Single-nucleotide polymorphism (SNP)-ischemic stroke associations were derived from three published open source European-ancestry results databases (cases/controls): MEGASTROKE (60,341/454,450), UK Biobank (2404/368,771) and FinnGen (10,551/202,223). MR was performed per study, and results were subsequently meta-analyzed.
In total, 288,572 unrelated participants (46% men) with mean (SD) age of 57 (8) years were included in the Cox-proportional hazard analyses. After correction for considered confounders (BMI, hypertension, cholesterol, T2D), no association was found between low versus high mtDNA abundance and ischemic (HR: 1.06 [95% CI: 0.95, 1.18]) or hemorrhagic (HR: 0.97 [95% CI: 0.82, 1.15]) stroke. However, in the MR analyses after removal of platelet count-associated SNPs, we found evidence for an association between genetically-influenced mtDNA abundance and ischemic stroke (odds ratio, 1.17; confidence interval, 1.03, 1.32).
Although the results from both multivariable-adjusted prospective and basis MR analyses did not show an association between low mtDNA and increased risk of ischemic stroke, in-depth MR sensitivity analyses may suggest evidence for a causal relationship.
线粒体功能障碍与活性氧(ROS)的增加有关,后者被认为会增加包括中风在内的疾病风险。我们通过多变量调整的生存分析和孟德尔随机分析(MR),研究了线粒体 DNA 丰度(作为线粒体功能的替代指标)与中风事件之间的关联。
在英国生物库的欧洲血统参与者中,进行 Cox 比例风险模型分析,以评估 mtDNA 丰度与缺血性和出血性中风事件之间的关联,随访时间最长可达 14 年。使用独立的(R<0.001)mtDNA 丰度的先导变异(p<5×10)作为工具变量进行 MR。单核苷酸多态性(SNP)-缺血性中风关联来自三个已发表的欧洲血统开放资源结果数据库(病例/对照):MEGASTROKE(60341/454450)、英国生物库(2404/368771)和 FinnGen(10551/202223)。在每个研究中进行 MR,并对结果进行汇总分析。
共有 288572 名无关联的参与者(46%为男性)纳入 Cox 比例风险分析,平均年龄(标准差)为 57(8)岁。在考虑了混杂因素(BMI、高血压、胆固醇、T2D)后,mtDNA 低丰度与高丰度与缺血性(HR:1.06[95%CI:0.95,1.18])或出血性(HR:0.97[95%CI:0.82,1.15])中风之间无关联。然而,在去除与血小板计数相关的 SNP 后的 MR 分析中,我们发现遗传影响的 mtDNA 丰度与缺血性中风之间存在关联(比值比,1.17;95%置信区间,1.03,1.32)。
尽管多变量调整的前瞻性和基础 MR 分析的结果均显示 mtDNA 低丰度与缺血性中风风险增加之间无关联,但深入的 MR 敏感性分析可能提示存在因果关系的证据。